1. Discuss the current evidence surrounding the use of tranexamic acid in obstetrics

2. Discuss fetal or neonatal impacts of tranexamic acid use in pregnancy

3. Understand pathogenesis of CPAM and natural progression in pregnancy

4. Recognize perinatal risks associated with CPAM and predictive markers of associated risks

5. Understand treatment options of CPAM in pregnancy and postnatal period


Session date: 
11/10/2016 - 8:00am to 9:00am CST
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Amanda Stephens, MD and Lena Braginsky MD